Analyst Price Target is $84.00
▲ +5,085.19% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Yield10 Bioscience in the last 3 months. The average price target is $84.00, with a high forecast of $96.00 and a low forecast of $72.00. The average price target represents a 5,085.19% upside from the last price of $1.62.
Current Consensus is
Hold
The current consensus among 3 polled investment analysts is to hold stock in Yield10 Bioscience. This Hold consensus rating has held steady for over two years.
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
Read More